HEADER VIRAL PROTEIN 04-OCT-20 7D7L TITLE THE CRYSTAL STRUCTURE OF SARS-COV-2 PAPAIN-LIKE PROTEASE IN COMPLEX TITLE 2 WITH YM155 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NON-STRUCTURAL PROTEIN 3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NSP3, PL2-PRO, PAPAIN-LIKE PROTEASE, PAPAIN-LIKE PROTEINASE, COMPND 5 PL-PRO; COMPND 6 EC: 3.4.19.121, 3.4.22.-; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: REP, 1A-1B; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_VARIANT: ROSETTA; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET-11A KEYWDS PROTEASE, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.ZHAO,L.SUN,H.T.YANG,Z.H.RAO REVDAT 3 17-NOV-21 7D7L 1 JRNL REVDAT 2 16-JUN-21 7D7L 1 TITLE JRNL REVDAT 1 21-APR-21 7D7L 0 JRNL AUTH Y.ZHAO,X.DU,Y.DUAN,X.PAN,Y.SUN,T.YOU,L.HAN,Z.JIN,W.SHANG, JRNL AUTH 2 J.YU,H.GUO,Q.LIU,Y.WU,C.PENG,J.WANG,C.ZHU,X.YANG,K.YANG, JRNL AUTH 3 Y.LEI,L.W.GUDDAT,W.XU,G.XIAO,L.SUN,L.ZHANG,Z.RAO,H.YANG JRNL TITL HIGH-THROUGHPUT SCREENING IDENTIFIES ESTABLISHED DRUGS AS JRNL TITL 2 SARS-COV-2 PLPRO INHIBITORS. JRNL REF PROTEIN CELL V. 12 877 2021 JRNL REFN ESSN 1674-8018 JRNL PMID 33864621 JRNL DOI 10.1007/S13238-021-00836-9 REMARK 2 REMARK 2 RESOLUTION. 2.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.49 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 61350 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.260 REMARK 3 FREE R VALUE TEST SET COUNT : 1998 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.4900 - 5.0800 1.00 4615 155 0.1859 0.1929 REMARK 3 2 5.0700 - 4.0300 1.00 4366 147 0.1483 0.2034 REMARK 3 3 4.0300 - 3.5200 1.00 4294 145 0.1585 0.1966 REMARK 3 4 3.5200 - 3.2000 1.00 4266 144 0.1748 0.1926 REMARK 3 5 3.2000 - 2.9700 1.00 4244 143 0.1833 0.2305 REMARK 3 6 2.9700 - 2.7900 1.00 4218 142 0.1852 0.2175 REMARK 3 7 2.7900 - 2.6500 1.00 4216 142 0.1869 0.2209 REMARK 3 8 2.6500 - 2.5400 1.00 4186 140 0.2010 0.2204 REMARK 3 9 2.5400 - 2.4400 1.00 4196 141 0.2050 0.2773 REMARK 3 10 2.4400 - 2.3600 1.00 4175 141 0.2276 0.2865 REMARK 3 11 2.3600 - 2.2800 1.00 4174 140 0.2344 0.2738 REMARK 3 12 2.2800 - 2.2200 1.00 4150 140 0.2445 0.2908 REMARK 3 13 2.2200 - 2.1600 1.00 4185 141 0.2575 0.3120 REMARK 3 14 2.1600 - 2.1100 0.97 4067 137 0.2761 0.3268 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.110 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7D7L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1300018852. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUL-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61372 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.110 REMARK 200 RESOLUTION RANGE LOW (A) : 48.490 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 39.35 REMARK 200 R MERGE (I) : 0.28100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.7100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.11 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 39.38 REMARK 200 R MERGE FOR SHELL (I) : 4.47600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.610 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS PH 8.0, 2.0M AMMONIUM REMARK 280 SULFATE, 0.033% W/V CAFFEINE, 0.033% W/V DITHIOERYTHRITOL, 0.033% REMARK 280 W/V L-METHIONINE, EVAPORATION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 171.53333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 85.76667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 128.65000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 42.88333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 214.41667 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 171.53333 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 85.76667 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 42.88333 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 128.65000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 214.41667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 C6 CFF B 402 LIES ON A SPECIAL POSITION. REMARK 375 O13 CFF B 402 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR B 4 OG1 CG2 REMARK 470 ILE B 5 CG1 CG2 CD1 REMARK 470 VAL B 7 CG1 CG2 REMARK 470 ASP B 22 CG OD1 OD2 REMARK 470 MET B 23 CG SD CE REMARK 470 MET B 25 CG SD CE REMARK 470 GLN B 29 CG CD OE1 NE2 REMARK 470 LYS B 45 CG CD CE NZ REMARK 470 HIS B 47 CG ND1 CD2 CE1 NE2 REMARK 470 ASN B 48 CG OD1 ND2 REMARK 470 HIS B 50 CG ND1 CD2 CE1 NE2 REMARK 470 GLU B 51 CG CD OE1 OE2 REMARK 470 LYS B 53 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 103 -169.12 -110.92 REMARK 500 ALA A 107 145.02 -171.21 REMARK 500 LYS A 279 -119.51 -119.80 REMARK 500 ASN A 308 -66.08 -135.65 REMARK 500 ASN B 13 -4.34 61.91 REMARK 500 MET B 23 6.39 -64.68 REMARK 500 PRO B 46 74.12 -54.96 REMARK 500 SER B 103 -168.72 -108.92 REMARK 500 LYS B 279 -122.78 -120.43 REMARK 500 ASN B 308 -60.75 -126.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 189 SG REMARK 620 2 CYS A 192 SG 123.0 REMARK 620 3 CYS A 224 SG 117.9 100.3 REMARK 620 4 CYS A 226 SG 87.5 116.3 112.4 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 189 SG REMARK 620 2 CYS B 192 SG 106.5 REMARK 620 3 CYS B 224 SG 113.3 107.9 REMARK 620 4 CYS B 226 SG 116.1 107.5 105.1 REMARK 620 N 1 2 3 DBREF 7D7L A 4 315 UNP P0DTD1 R1AB_SARS2 1567 1878 DBREF 7D7L B 4 315 UNP P0DTD1 R1AB_SARS2 1567 1878 SEQADV 7D7L SER A 111 UNP P0DTD1 CYS 1674 ENGINEERED MUTATION SEQADV 7D7L SER B 111 UNP P0DTD1 CYS 1674 ENGINEERED MUTATION SEQRES 1 A 312 THR ILE LYS VAL PHE THR THR VAL ASP ASN ILE ASN LEU SEQRES 2 A 312 HIS THR GLN VAL VAL ASP MET SER MET THR TYR GLY GLN SEQRES 3 A 312 GLN PHE GLY PRO THR TYR LEU ASP GLY ALA ASP VAL THR SEQRES 4 A 312 LYS ILE LYS PRO HIS ASN SER HIS GLU GLY LYS THR PHE SEQRES 5 A 312 TYR VAL LEU PRO ASN ASP ASP THR LEU ARG VAL GLU ALA SEQRES 6 A 312 PHE GLU TYR TYR HIS THR THR ASP PRO SER PHE LEU GLY SEQRES 7 A 312 ARG TYR MET SER ALA LEU ASN HIS THR LYS LYS TRP LYS SEQRES 8 A 312 TYR PRO GLN VAL ASN GLY LEU THR SER ILE LYS TRP ALA SEQRES 9 A 312 ASP ASN ASN SER TYR LEU ALA THR ALA LEU LEU THR LEU SEQRES 10 A 312 GLN GLN ILE GLU LEU LYS PHE ASN PRO PRO ALA LEU GLN SEQRES 11 A 312 ASP ALA TYR TYR ARG ALA ARG ALA GLY GLU ALA ALA ASN SEQRES 12 A 312 PHE CYS ALA LEU ILE LEU ALA TYR CYS ASN LYS THR VAL SEQRES 13 A 312 GLY GLU LEU GLY ASP VAL ARG GLU THR MET SER TYR LEU SEQRES 14 A 312 PHE GLN HIS ALA ASN LEU ASP SER CYS LYS ARG VAL LEU SEQRES 15 A 312 ASN VAL VAL CYS LYS THR CYS GLY GLN GLN GLN THR THR SEQRES 16 A 312 LEU LYS GLY VAL GLU ALA VAL MET TYR MET GLY THR LEU SEQRES 17 A 312 SER TYR GLU GLN PHE LYS LYS GLY VAL GLN ILE PRO CYS SEQRES 18 A 312 THR CYS GLY LYS GLN ALA THR LYS TYR LEU VAL GLN GLN SEQRES 19 A 312 GLU SER PRO PHE VAL MET MET SER ALA PRO PRO ALA GLN SEQRES 20 A 312 TYR GLU LEU LYS HIS GLY THR PHE THR CYS ALA SER GLU SEQRES 21 A 312 TYR THR GLY ASN TYR GLN CYS GLY HIS TYR LYS HIS ILE SEQRES 22 A 312 THR SER LYS GLU THR LEU TYR CYS ILE ASP GLY ALA LEU SEQRES 23 A 312 LEU THR LYS SER SER GLU TYR LYS GLY PRO ILE THR ASP SEQRES 24 A 312 VAL PHE TYR LYS GLU ASN SER TYR THR THR THR ILE LYS SEQRES 1 B 312 THR ILE LYS VAL PHE THR THR VAL ASP ASN ILE ASN LEU SEQRES 2 B 312 HIS THR GLN VAL VAL ASP MET SER MET THR TYR GLY GLN SEQRES 3 B 312 GLN PHE GLY PRO THR TYR LEU ASP GLY ALA ASP VAL THR SEQRES 4 B 312 LYS ILE LYS PRO HIS ASN SER HIS GLU GLY LYS THR PHE SEQRES 5 B 312 TYR VAL LEU PRO ASN ASP ASP THR LEU ARG VAL GLU ALA SEQRES 6 B 312 PHE GLU TYR TYR HIS THR THR ASP PRO SER PHE LEU GLY SEQRES 7 B 312 ARG TYR MET SER ALA LEU ASN HIS THR LYS LYS TRP LYS SEQRES 8 B 312 TYR PRO GLN VAL ASN GLY LEU THR SER ILE LYS TRP ALA SEQRES 9 B 312 ASP ASN ASN SER TYR LEU ALA THR ALA LEU LEU THR LEU SEQRES 10 B 312 GLN GLN ILE GLU LEU LYS PHE ASN PRO PRO ALA LEU GLN SEQRES 11 B 312 ASP ALA TYR TYR ARG ALA ARG ALA GLY GLU ALA ALA ASN SEQRES 12 B 312 PHE CYS ALA LEU ILE LEU ALA TYR CYS ASN LYS THR VAL SEQRES 13 B 312 GLY GLU LEU GLY ASP VAL ARG GLU THR MET SER TYR LEU SEQRES 14 B 312 PHE GLN HIS ALA ASN LEU ASP SER CYS LYS ARG VAL LEU SEQRES 15 B 312 ASN VAL VAL CYS LYS THR CYS GLY GLN GLN GLN THR THR SEQRES 16 B 312 LEU LYS GLY VAL GLU ALA VAL MET TYR MET GLY THR LEU SEQRES 17 B 312 SER TYR GLU GLN PHE LYS LYS GLY VAL GLN ILE PRO CYS SEQRES 18 B 312 THR CYS GLY LYS GLN ALA THR LYS TYR LEU VAL GLN GLN SEQRES 19 B 312 GLU SER PRO PHE VAL MET MET SER ALA PRO PRO ALA GLN SEQRES 20 B 312 TYR GLU LEU LYS HIS GLY THR PHE THR CYS ALA SER GLU SEQRES 21 B 312 TYR THR GLY ASN TYR GLN CYS GLY HIS TYR LYS HIS ILE SEQRES 22 B 312 THR SER LYS GLU THR LEU TYR CYS ILE ASP GLY ALA LEU SEQRES 23 B 312 LEU THR LYS SER SER GLU TYR LYS GLY PRO ILE THR ASP SEQRES 24 B 312 VAL PHE TYR LYS GLU ASN SER TYR THR THR THR ILE LYS HET ZN A 401 1 HET CFF A 402 14 HET GXU A 403 27 HET GXU A 404 27 HET SO4 A 405 5 HET SO4 A 406 5 HET SO4 A 407 5 HET SO4 A 408 5 HET SO4 A 409 5 HET GOL A 410 6 HET GOL A 411 6 HET ZN B 401 1 HET CFF B 402 14 HET GXU B 403 27 HET GXU B 404 27 HET GXU B 405 27 HET SO4 B 406 5 HET SO4 B 407 5 HET SO4 B 408 5 HET SO4 B 409 5 HETNAM ZN ZINC ION HETNAM CFF CAFFEINE HETNAM GXU 1-(2-METHOXYETHYL)-2-METHYL-3-(PYRAZIN-2-YLMETHYL) HETNAM 2 GXU BENZO[F]BENZIMIDAZOL-3-IUM-4,9-DIONE HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN CFF 3,7-DIHYDRO-1,3,7-TRIMETHYL-1H-PURINE-2,6-DIONE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 ZN 2(ZN 2+) FORMUL 4 CFF 2(C8 H10 N4 O2) FORMUL 5 GXU 5(C20 H19 N4 O3 1+) FORMUL 7 SO4 9(O4 S 2-) FORMUL 12 GOL 2(C3 H8 O3) FORMUL 23 HOH *419(H2 O) HELIX 1 AA1 THR A 26 GLY A 32 1 7 HELIX 2 AA2 HIS A 47 GLU A 51 5 5 HELIX 3 AA3 ASP A 61 HIS A 73 1 13 HELIX 4 AA4 SER A 78 LYS A 91 1 14 HELIX 5 AA5 ASN A 110 GLN A 121 1 12 HELIX 6 AA6 PRO A 129 GLY A 142 1 14 HELIX 7 AA7 ALA A 144 ASN A 156 1 13 HELIX 8 AA8 ASP A 164 HIS A 175 1 12 HELIX 9 AA9 GLY A 201 VAL A 205 1 5 HELIX 10 AB1 SER A 212 GLY A 219 1 8 HELIX 11 AB2 THR B 26 PHE B 31 1 6 HELIX 12 AB3 ASP B 61 HIS B 73 1 13 HELIX 13 AB4 SER B 78 LYS B 91 1 14 HELIX 14 AB5 ASN B 110 GLN B 121 1 12 HELIX 15 AB6 PRO B 129 ALA B 141 1 13 HELIX 16 AB7 ALA B 144 ASN B 156 1 13 HELIX 17 AB8 ASP B 164 GLN B 174 1 11 HELIX 18 AB9 GLY B 201 VAL B 205 1 5 HELIX 19 AC1 SER B 212 GLY B 219 1 8 SHEET 1 AA1 5 HIS A 17 VAL A 21 0 SHEET 2 AA1 5 ILE A 5 THR A 10 -1 N ILE A 5 O VAL A 21 SHEET 3 AA1 5 THR A 54 VAL A 57 1 O PHE A 55 N PHE A 8 SHEET 4 AA1 5 THR A 34 LEU A 36 -1 N TYR A 35 O TYR A 56 SHEET 5 AA1 5 ALA A 39 ASP A 40 -1 O ALA A 39 N LEU A 36 SHEET 1 AA2 2 GLN A 97 VAL A 98 0 SHEET 2 AA2 2 LEU A 101 THR A 102 -1 O LEU A 101 N VAL A 98 SHEET 1 AA3 4 GLY A 193 LYS A 200 0 SHEET 2 AA3 4 LYS A 182 CYS A 189 -1 N CYS A 189 O GLY A 193 SHEET 3 AA3 4 GLN A 229 GLU A 238 -1 O VAL A 235 N VAL A 184 SHEET 4 AA3 4 VAL A 220 PRO A 223 -1 N VAL A 220 O LYS A 232 SHEET 1 AA4 4 GLY A 193 LYS A 200 0 SHEET 2 AA4 4 LYS A 182 CYS A 189 -1 N CYS A 189 O GLY A 193 SHEET 3 AA4 4 GLN A 229 GLU A 238 -1 O VAL A 235 N VAL A 184 SHEET 4 AA4 4 SER A 309 THR A 311 -1 O TYR A 310 N GLN A 237 SHEET 1 AA5 7 MET A 206 MET A 208 0 SHEET 2 AA5 7 PHE A 241 LEU A 253 1 O SER A 245 N TYR A 207 SHEET 3 AA5 7 TYR A 296 LYS A 306 -1 O VAL A 303 N MET A 244 SHEET 4 AA5 7 CYS A 260 GLY A 266 -1 N CYS A 260 O PHE A 304 SHEET 5 AA5 7 GLY A 271 SER A 278 -1 O LYS A 274 N GLU A 263 SHEET 6 AA5 7 LEU A 282 ASP A 286 -1 O TYR A 283 N THR A 277 SHEET 7 AA5 7 LEU A 289 SER A 293 -1 O LEU A 289 N ASP A 286 SHEET 1 AA6 5 HIS B 17 THR B 18 0 SHEET 2 AA6 5 PHE B 8 THR B 10 -1 N THR B 9 O HIS B 17 SHEET 3 AA6 5 THR B 54 VAL B 57 1 O PHE B 55 N PHE B 8 SHEET 4 AA6 5 THR B 34 LEU B 36 -1 N TYR B 35 O TYR B 56 SHEET 5 AA6 5 ALA B 39 ASP B 40 -1 O ALA B 39 N LEU B 36 SHEET 1 AA7 2 GLN B 97 VAL B 98 0 SHEET 2 AA7 2 LEU B 101 THR B 102 -1 O LEU B 101 N VAL B 98 SHEET 1 AA8 4 GLY B 193 LYS B 200 0 SHEET 2 AA8 4 LYS B 182 CYS B 189 -1 N ARG B 183 O LEU B 199 SHEET 3 AA8 4 GLN B 229 GLU B 238 -1 O GLN B 236 N VAL B 184 SHEET 4 AA8 4 VAL B 220 PRO B 223 -1 N ILE B 222 O ALA B 230 SHEET 1 AA9 4 GLY B 193 LYS B 200 0 SHEET 2 AA9 4 LYS B 182 CYS B 189 -1 N ARG B 183 O LEU B 199 SHEET 3 AA9 4 GLN B 229 GLU B 238 -1 O GLN B 236 N VAL B 184 SHEET 4 AA9 4 SER B 309 THR B 311 -1 O TYR B 310 N GLN B 237 SHEET 1 AB1 7 MET B 206 MET B 208 0 SHEET 2 AB1 7 PHE B 241 LEU B 253 1 O SER B 245 N TYR B 207 SHEET 3 AB1 7 TYR B 296 LYS B 306 -1 O VAL B 303 N MET B 244 SHEET 4 AB1 7 CYS B 260 GLY B 266 -1 N CYS B 260 O PHE B 304 SHEET 5 AB1 7 GLY B 271 SER B 278 -1 O LYS B 274 N GLU B 263 SHEET 6 AB1 7 LEU B 282 ASP B 286 -1 O TYR B 283 N THR B 277 SHEET 7 AB1 7 LEU B 289 SER B 293 -1 O THR B 291 N CYS B 284 SSBOND 1 CYS A 270 CYS A 270 1555 10555 2.40 SSBOND 2 CYS B 270 CYS B 270 1555 10555 2.37 LINK SG CYS A 189 ZN ZN A 401 1555 1555 2.22 LINK SG CYS A 192 ZN ZN A 401 1555 1555 2.21 LINK SG CYS A 224 ZN ZN A 401 1555 1555 2.21 LINK SG CYS A 226 ZN ZN A 401 1555 1555 2.22 LINK SG CYS B 189 ZN ZN B 401 1555 1555 2.22 LINK SG CYS B 192 ZN ZN B 401 1555 1555 2.27 LINK SG CYS B 224 ZN ZN B 401 1555 1555 2.23 LINK SG CYS B 226 ZN ZN B 401 1555 1555 2.27 CRYST1 117.560 117.560 257.300 90.00 90.00 120.00 P 65 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008506 0.004911 0.000000 0.00000 SCALE2 0.000000 0.009822 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003887 0.00000